openPR Logo
Press release

Organoids Market for Drug Discovery, Chronic Disease Modeling, GI Research, and North America Biotech Growth | Keyplayers - Mirus Bio LLC, ACROBiosystems, Danaher Corporation, ATCC among others

Organoids Market

Organoids Market

Organoids Market reached US$ 1.64 Billion in 2024 and is expected to reach US$ 6.41 Billion by 2033, growing at a CAGR of 16.5% during the forecast period 2025-2033.

The Organoids Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Request a Premium Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/organoids-market?sv

Market Overview :

The organoids market is rapidly expanding due to rising cases of chronic diseases like cancer, diabetes, and cardiovascular conditions. Organoids offer a breakthrough in replicating human organ functions, making them indispensable for personalized medicine and drug discovery.

Evolving Market Forces and Opportunities:

The increasing need for human-relevant models is driving pharmaceutical firms to adopt organoids in R&D workflows, improving the accuracy of disease modeling and drug screening. However, high development costs and the need for sophisticated infrastructure pose challenges creating opportunities for innovation in cost-efficient, scalable organoid platforms.

List of the Key Players in the Organoids Market:

Thermo Fisher Scientific Inc, Merck KGaA, QIAGEN N.V, MERIDIAN BIOSCIENCE Inc, New England Biolabs, Mirus Bio LLC, ACROBiosystems, Danaher Corporation, ATCC, and AxoSim among others.

Research Methodology:

Both primary and secondary data sources have been used in the global Organoids Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://datamintelligence.com/enquiry/organoids-market?sv

Segment Covered in the Organoids Market:

By Product Type: Intestinal Organoids, Hepatic Organoids, Pancreatic Organoids, Colorectal Organoids, Neural Organoids, Others.

By Application: Bio-banking, Infectious Disease Pathology, Personalized Medicine, Biomedical Research and Drug Discovery, Regenerative Medicine, Cancer Research, Therapeutic Tools, Others.

BY END-USER; Biopharmaceutical Companies, Contract Research, Organizations, Academics and Research Institutes.

Regional Analysis for Organoids Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Organoids Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Organoids market?

➠ Who are the top manufacturers in the global Organoids industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Organoids market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Organoids market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Organoids industry landscape?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sv

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Organoids Market for Drug Discovery, Chronic Disease Modeling, GI Research, and North America Biotech Growth | Keyplayers - Mirus Bio LLC, ACROBiosystems, Danaher Corporation, ATCC among others here

News-ID: 4056439 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Ankle Replacement Devices Market 2033 | Growth Drivers, Key Players & Investment Opportunities
United States Ankle Replacement Devices Market 2033 | Growth Drivers, Key Player …
Market Size and Growth The global Ankle replacement devices market size reached US$ 1.12 Billion in 2024 from US$ 1.04 Billion in 2023 and is expected to reach US$ 2.38 Billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/ankle-replacement-devices-market?sb Key Development: United States: Recent Ankle Replacement Device Developments ✅ In December 2025, Medline received
United States Image Optimization Market 2031 | Growth Drivers, Key Players & Investment Opportunities
United States Image Optimization Market 2031 | Growth Drivers, Key Players & Inv …
Market Size and Growth Global Image Optimization Market reached US$ 153.2 Million in 2023 and is expected to reach US$ 238.7 Million by 2031, growing with a CAGR of 5.7% during the forecast period 2024-2031. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/image-optimization-market?sb Key Development: United States: Recent Image Optimization Developments ✅ In December 2025, ImageKit.io launched an AI-enhanced image optimization platform featuring real-time adaptive compression and
United states DNA Forensics Market to Reach USD 5.60 Billion by 2033 | CAGR 7.7% | North America Leads with 38% Share | Key Players: Abbott, Promega, Thermo Fisher, QIAGEN, Illumina, InVita, Omega Bio-tek, Takara Bio, SCIEX, Bio-Rad
United states DNA Forensics Market to Reach USD 5.60 Billion by 2033 | CAGR 7.7% …
DNA Forensics Market The global DNA forensics market reached US$ 2.90 billion in 2023, growing to US$ 3.09 billion in 2024, and is projected to reach US$ 5.60 billion by 2033, expanding at a CAGR of 7.7% during the forecast period 2025-2033. The market's growth is driven by rapid advancements in DNA forensics technologies, which are transforming criminal investigations and judicial processes. Modern genetic profiling and advanced sequencing techniques enable
United States Probiotic Skin Care Products Market 2031 | Growth Drivers, Key Players & Investment Opportunities
United States Probiotic Skin Care Products Market 2031 | Growth Drivers, Key Pla …
Market Size and Growth Global Probiotic Skin Care Products Market reached US$ 330.1 million in 2023 and is expected to reach US$ 607.3 million by 2031, growing with a CAGR of 9.1% during the forecast period 2024-2031. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/probiotic-skin-care-products-market?sb Key Development: United States: Recent Probiotic Skin Care Developments ✅ In December 2025, Glowbiotics probiotic skincare products featured in top seasonal beauty

All 5 Releases


More Releases for Organoids

Biocomputer Based on Organoids Market Poised for 16.3% CAGR Driven by Brain Orga …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biocomputer Based on Organoids Market Size, Share & Trends Analysis Report By Organoid Type (Brain Organoids, Other Organoids), Application (Biological Computing, Neuroscience Research, Drug Discovery and Testing, Personalized Medicine, Regenerative Medicine), Technology (Microfluidic Systems Microelectrode Arrays (MEAs), Brain-Machine Interfaces, CRISPR and Gene Editing), End-User (Academic and Research Institutes, Biotechnology and Pharmaceutical Companies, Technology Companies, Contract
Organoids: A Guide to Understanding the Process
Organoids are emerging as a powerful asset for researchers and drug developers as they seek more efficient and accurate methods to identify promising drug candidates and predict their efficacy. The ability to generate patient-derived organoids (PDOs) opens up exciting possibilities for personalized drug screening. Organoids serve as realistic and relevant models for drug screening compared to traditional 2D cell cultures. They mimic the complexity of human organs, including their cellular
Patient-derived organoids open doors to personalized medicine
Recent advances in organoid technology have opened the possibility of revolutionizing basic research, drug discovery and development, and patient treatment. Scientists are exploring the feasibility of using patient-derived organoids (PDOs) to develop and test personalized and regenerative medicine for certain cancer subtypes. Although this shows promise, broad adoption of organoids in drug discovery studies still faces many challenges, such as inconsistent quality, poor yield, slow data acquisition, and inaccurate data processing. We
Organoids Market - Pioneering Solutions for Personalized Medicine: Organoids Sha …
Newark, New Castle, USA - new report, titled Organoids Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Organoids market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Organoids market. The report offers an overview of the market, which briefly describes the
Organoids and Spheroids Market Emerging Trends 2023-2030
The worldwide organoids and spheroids market size was estimated at USD 405.3 million in 2021 and is supposed to develop yearly from 2022 to 2028. Utilization of the organoids and spheroids models to uncover what the COVID-19 infection means for a few digestive cells is supposed to drive the reception of organoids in research. Researchers have been involving these frameworks for testing and recognizable proof of promising prescriptions. Organizations take
Sweden Organoids Market Scrutinized in New Research 2030
Organoids Market: Introduction According to the report, the global organoids market was valued over US$ 1.7 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030. Organoids are replicated or miniaturized versions of organs such as stomach, liver, lung, kidney, and brain produced from stems cells in vitro. These miniature models are three-dimensional tissue culture derived from stem cells. The stem cells are derived from pluripotent and